India markets closed
  • BSE SENSEX

    52,586.84
    -66.23 (-0.13%)
     
  • Nifty 50

    15,763.05
    -15.40 (-0.10%)
     
  • USD/INR

    74.3370
    -0.1630 (-0.22%)
     
  • Dow

    34,935.47
    -149.06 (-0.42%)
     
  • Nasdaq

    14,672.68
    -105.59 (-0.71%)
     
  • BTC-INR

    3,094,509.75
    +201,329.75 (+6.96%)
     
  • CMC Crypto 200

    955.03
    +5.13 (+0.54%)
     
  • Hang Seng

    25,961.03
    -354.29 (-1.35%)
     
  • Nikkei

    27,283.59
    -498.83 (-1.80%)
     
  • EUR/INR

    88.2728
    +0.0141 (+0.02%)
     
  • GBP/INR

    103.3329
    -0.2571 (-0.25%)
     
  • AED/INR

    20.1940
    -0.0450 (-0.22%)
     
  • INR/JPY

    1.4721
    -0.0004 (-0.03%)
     
  • SGD/INR

    54.9030
    -0.0380 (-0.07%)
     

Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

·5-min read

LONDON, Jun 14, 2021--(BUSINESS WIRE)--

FORM 8.3 Amendment to purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)

Barclays PLC.

Company dealt in

WILLIS TOWERS WATSON PLC

Class of relevant security to which the dealings being disclosed relate (Note 2)

ORD

Date of dealing

10 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

1,881,452

1.46%

230,795

0.18%

(2)

Derivatives (other than options):

72,359

0.06%

94,581

0.07%

(3)

Options and agreements to

purchase/sell:

6,100

0.00%

6,100

0.00%

TOTAL:

1,959,911

1.52%

331,476

0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

Number

(%)

Number

(%)

(1) Relevant securities

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit

Purchase

2

258.1200 USD

Purchase

7

256.2000 USD

Purchase

96

256.3458 USD

Purchase

100

256.5800 USD

Purchase

100

259.0800 USD

Purchase

100

259.1500 USD

Purchase

170

256.6664 USD

Purchase

380

257.9323 USD

Purchase

400

256.8695 USD

Purchase

621

258.0479 USD

Purchase

632

258.2614 USD

Purchase

1,425

258.0747 USD

Purchase

1,630

257.2892 USD

Purchase

2,088

258.2177 USD

Purchase

2,795

257.5000 USD

Purchase

3,324

257.4996 USD

Purchase

5,790

257.4454 USD

Purchase

9,601

258.8881 USD

Purchase

13,546

257.6854 USD

Purchase

14,050

258.0332 USD

Sale

9

257.7200 USD

Sale

18

257.8233 USD

Sale

55

257.3800 USD

Sale

70

257.9200 USD

Sale

100

258.3100 USD

Sale

100

257.3950 USD

Sale

155

257.9700 USD

Sale

162

257.7117 USD

Sale

200

257.3750 USD

Sale

300

257.8733 USD

Sale

400

256.8695 USD

Sale

550

258.1870 USD

Sale

580

258.2054 USD

Sale

601

257.3371 USD

Sale

649

258.0523 USD

Sale

869

257.3640 USD

Sale

1,040

257.3584 USD

Sale

1,346

257.3989 USD

Sale

1,407

258.0779 USD

Sale

1,549

257.5000 USD

Sale

1,991

256.8376 USD

Sale

2,009

257.2895 USD

Sale

2,024

257.4051 USD

Sale

3,324

257.4996 USD

Sale

3,343

257.9917 USD

Sale

4,158

257.5763 USD

Sale

4,349

257.7358 USD

Sale

11,853

258.0681 USD

Sale

13,000

258.7619 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure

14 June 2021

Contact name

Large Holdings Regulatory Operations

Telephone number

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected

If a connected EFM, state nature of connection (Note 10)

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name

Written or

Number of

Exercise

Type

Expiry

purchased

relevant securities

price

date

to which the option

or derivative

relates

Put Options

Purchased

-100

220.0000

American

Jul 16, 2021

Call Options

Purchased

100

240.0000

American

Jul 16, 2021

Call Options

Purchased

6,000

220.0000

American

Jul 16, 2021

Put Options

Purchased

-6,000

200.0000

American

Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210614005407/en/

Contacts

BARCLAYS PLC

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting